PADDAS syndrome associated with hair dysplasia caused by a de novo missense variant of PUM1.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
06 2019
Historique:
received: 05 12 2018
revised: 31 01 2019
accepted: 05 03 2019
pubmed: 25 3 2019
medline: 11 6 2020
entrez: 24 3 2019
Statut: ppublish

Résumé

PUM1 has been very recently reported as responsible for a new form of developmental disorder named PADDAS syndrome. We describe here an additional patient with early onset developmental delay, epilepsy, microcephaly, and hair dysplasia, with a de novo heterozygous missense variant of PUM1: c.3439C > T, p.(Arg1147Trp). This variant was absent from databases and predicted deleterious by multiple softwares. The same missense variant has been reported by Gennarino et al., in a girl with much more severe epilepsy. Our report is in favor of a variable expressivity of PADDAS syndrome, and broadens the phenotypic spectrum with the description of hair dysplasia.

Identifiants

pubmed: 30903679
doi: 10.1002/ajmg.a.61127
doi:

Substances chimiques

PUM1 protein, human 0
RNA-Binding Proteins 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1033

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Paul Bonnemason-Carrere (P)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.

Fanny Morice-Picard (F)

Department of Dermatology, Paediatric Dermatology Unit, National Reference Center for Rare Skin Disorders, CHU Bordeaux, Bordeaux, France.

Perrine Pennamen (P)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Benoit Arveiler (B)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Patricia Fergelot (P)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Cyril Goizet (C)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Mélanie Hellegouarch (M)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.

Didier Lacombe (D)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Claudio Plaisant (C)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.

Virginie Raclet (V)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.

Caroline Rooryck (C)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Eulalie Lasseaux (E)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.

Aurélien Trimouille (A)

Department of Medical Genetics, CHU Bordeaux, Bordeaux, France.
Maladies Rares: Génétique et Métabolisme (MRGM), Inserm U1211, University of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH